{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-080474","form_type":"8-K","ticker":"BJDX","cik":"0001704287","company_name":"Bluejay Diagnostics, Inc.","filed_at":"2026-07-22T21:25:23+00:00","discovered_at":"2026-07-22T21:26:00.268554+00:00","generated_at":"2026-07-22T21:26:05.991417+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Bluejay Diagnostics completes enrollment of 750 patients in SYMON-II sepsis study ahead of schedule","bullets":["Enrolled 750 patients ahead of plan in pivotal SYMON-II study evaluating Symphony IL-6 for early sepsis mortality risk assessment.","Preliminary observations indicate an approximately 17% 28-day mortality rate, providing a robust clinical dataset.","Study enrolled patients across leading U.S. healthcare institutions; results to support planned 510(k) submission to FDA.","Company expects to complete data cleaning, statistical analysis, and clinical reporting over the coming months."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-080474","json":"https://secwatch.observer/filing/0001213900-26-080474.json","markdown":"https://secwatch.observer/filing/0001213900-26-080474.md","text":"https://secwatch.observer/filing/0001213900-26-080474.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1704287/000121390026080474/0001213900-26-080474-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1704287/000121390026080474/ea0298955-8k_bluejay.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-22T21:26:05.991417+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}